
Opinion|Videos|March 19, 2025
Treatment Decision-Making for Metastatic NSCLC With a ROS1 Alteration
Panelists discuss treatment decision-making for metastatic non–-small cell lung cancer (NSCLC) with a ROS1 alteration, focusing on targeted therapies and personalized treatment strategies.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement







































